China Issues Draft Document on Innovative Chemical Drug Pricing
On February 5th, China’s National Healthcare Security Administration (NHSA) made public a declaration titled – Establishing a Price Formation Mechanism for newly-listed chemical drugs to encourage high-quality innovation. Basically, the Chinese government acknowledged that in its pricing process, highly innovative and less... Read More